Acyclovir plus CMV immunoglobulin prophylaxis and early therapy with ganciclovir are effective and safe in CMV high-risk renal transplant pediatric recipients

F. Ginevri, G. Losurdo, I. Fontana, A. M. Rabagliati, L. Bonatto, R. Valente, P. Venzano, A. Nocera, G. C. Basile, U. Valente, R. Gusmano

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Acyclovir plus CMV immunoglobulin prophylaxis and early therapy with ganciclovir are effective and safe in CMV high-risk renal transplant pediatric recipients'. Together they form a unique fingerprint.

Medicine & Life Sciences